In a research report published today, Piper Jaffray analyst Joshua Schimmer offered some favorable commentary on GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) after attending a one-day course at …
GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, …
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced …
In a research report published today, Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) with a price …
GW Pharmaceuticals PLC- ADR (Nasdaq:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today noted …
GW Pharmaceuticals PLC- ADR (Nasdaq:GWPH) (AIM:GWP), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, …